Predominant contribution of IFN-β expression to apoptosis induction in human uterine cervical fibroblast cells by influenza-virus infection

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 11, 2004, Pages 1750-1757

  Ohyama, Kunio ^a   Sano, Tomomi ^a   Toyoda, Hiroo ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Anti viral defense; Apoptosis; Influenza virus infection; Interferon (IFN)

Indexed keywords

2 AMINOPURINE; ALPHA INTERFERON; BETA INTERFERON; DNA FRAGMENT; DOUBLE STRANDED RNA; FAS LIGAND; INDOLEAMINE; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; SYNTHETASE; TUMOR NECROSIS FACTOR ALPHA; POLYINOSINIC POLYCYTIDYLIC ACID;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE INDUCTION; HOST RESISTANCE; HUMAN; HUMAN CELL; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MOLECULAR MECHANICS; PROTEIN EXPRESSION; UTERINE CERVIX; AGAR GEL ELECTROPHORESIS; BIOSYNTHESIS; CELL CULTURE; CELL SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; VIROLOGY; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CERVIX UTERI; DNA FRAGMENTATION; ELECTROPHORESIS, AGAR GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; HUMANS; INFLUENZA, HUMAN; INFLUENZAVIRUS A; INFLUENZAVIRUS B; INTERFERON-BETA; POLY I-C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 22044438960     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1750     Document Type: Article

References (35)

1. Uchide N., Ohyama K., Bessho B., Yamakawa T., Biol. Pharm. Bull., 25, 109-114 (2002).
2. Uchide N., Ohyama K., Bessho B., Sano T., Yamakawa T., Biol. Pharm. Bull., 25, 239-243 (2002).
3. Grossman J. H., Dennis L. G., "The Human Placenta", ed. by Lavery J. P., Aspen Publishers Inc., U.S.A., 1989, pp. 131-154.
4. Rosztoczy I., Sweet C., Toms G. L., Smith H., Br. J. Exp. Path., 56, 322-328 (1975).
5. McGregor J. A., Burns J. C., Levin M. J., Burlington B., Meiklejohn G., Am. J. Obstet. Gynecol., 149, 856-859 (1984).
6. Stanwell-Smith R., Parker A. M., Chakraverty P., Soltanpoor N., Simptom C. N., Commun. Dis. Rep. CDR. Rev., 4, R28-32 (1994).
7. Ohyama K., Oka K., Emura A., Tamura H., Suga T., Bessho T., Hirakawa S., Yamakawa T., Biol. Pharm. Bull., 21, 1024-1029 (1998).
8. Uchide N., Ohyama K., Bessho T., Yuan B., Yamakawa T., Antiviral Res., 56, 207-217 (2002).
9. Ohyama K., Nishina M., Yuan B., Bessho T., Yamakawa T., Biol. Pharm. Bull., 26, 141-147 (2003).
10. Ohyama K., Enn P., Uchide N., Bessho T., Yamakawa T., Biol. Phram. Bull., 24, 342-346 (2001).
11. Watanabe W., Sudo K., Asawa S., Konno K., Yokota T., Shigeta S., J. Virol. Methods, 51, 185-191 (1995).
12. Laemmli U. K., Nature (London), 227, 680-685 (1970).
13. Bradford M. M., Anal. Biochem., 72, 248-254 (1976).
14. Gavrieli Y., Sgerman Y., Ben-Sasson S. A., J. Cell. Biol., 119, 493-501 (1992).
15. Wyllie A. H., Kerr J. H. R., Currie A. R., Int. Rev. Cytol., 68, 251-306 (1980).
16. Takizawa T., Fukuda R., Miyakawa T., Ohashi K., Nakanishi Y., Virology, 209, 288-296 (1995).
17. Kito M., Akao Y., Ohishi N., Yagi K., Biochem. Biophys. Res. Commun., 257, 771-776 (1999).
18. Obora A., Shiratori Y., Okuno M., Adachi S., Takano Y., Matsushima-Nishiwaki R., Yasuda I., Yamada Y., Akita K., Sano T., Shimada J., Kojima S., Okano Y., Friedman S. L., Moriwaki H., Hepatology, 36, 1115-1124 (2002).
19. Ronni T., Sareneva T., Pirhonen J., Julkunen I., J. Immunol., 154, 2764-2774 (1995).
20. Sancéau J., Hiscott J., Delattre O., Wietzerbin J., Oncogene, 19, 3372-3383 (2000).
21. Mori K., Yoshida K., Tani J., Nakagawa Y., Hoshikawa S., Ito S., Mol. Cell Endocrinol., 184, 77-86 (2001).
22. Clemens M. J., Int. J. Biochem. Cell Biol., 29, 945-949 (1997).
23. Balachandran S., Roberts P. C., Brown L. E., Truong H., Pattnaik A. K., Archer D. R., Barber G. N., Immunity, 13, 129-141 (2000).
24. Castelli J., Wood K. A., Youle R. J., Biomed. Pharmacother., 52, 386-390 (1998).
25. Castelli J. C., Hassel B. A., Maran A., Paranjape J., Hewitt J. A., Li X. L., Hsu Y. T., Silverman R. H., Youle R. J., Cell Death Differ., 5, 313-320 (1998).
26. Taylor M. W., Ferg G. S., FASEB J., 5, 2516-2522 (1991).
27. Leung B. S., Stout L. E., Shaskan E. G., Thompson R. M., Cancer Lett., 66, 77-81 (1992).
28. Grant R. S., Naif H., Espinosa M., Kapoor V., Redox Rep., 5, 101-104 (2000).
29. Ozes O. N., Taylor M. W., J. Interferon Res., 14, 25-32 (1994).
30. Itoh N., Yonehara S., Ishii A., Yonehara M., Mizushima S., Sameshima M., Hase A., Seto Y., Nagata S., Cell, 66, 233-243 (1991).
31. Oehm A., Behrmann I., Falk W., Pawlita M., Maier G., Klas C., Li-Weber M., Richards S., Dhein J., Trauth B. C., J. Biol. Chem., 267, 10709-10715 (1992).
32. Takizawa T., Matsukawa S., Higuchi Y., Nakamura S., Nakanishi Y., Fukuda R., J. Gen. Virol., 74, 2347-2355 (1993).
33. Oyaizu N., McCloskey T. W., Than S., Hu R., Kalyanaraman V. S., Pahwa S., Blood, 84, 2622-2631 (1994).
34. Hsu H., Xiong J., Goeddel D. V., Cell, 81, 495-504 (1995).
35. Barber G. N., Cell Death Differ., 8, 113-126 (2000).